Lenalidomide enhances anti-myeloma cellular immunity

Lenalidomide is an effective therapeutic agent for multiple myeloma that exhibits immunomodulatory properties including the activation of T and NK cells. The use of lenalidomide to reverse tumor-mediated immune suppression and amplify myeloma-specific immunity is currently being explored. In the pre...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Luptakova, Katarina, Rosenblatt, Jacalyn, Glotzbecker, Brett, Mills, Heidi, Stroopinsky, Dina, Kufe, Turner, Vasir, Baldev, Arnason, Jon, Tzachanis, Dimitri, Zwicker, Jeffrey I., Joyce, Robin M., Levine, James D., Anderson, Kenneth C., Kufe, Donald, Avigan, David
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer-Verlag 2012
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4098790/
https://ncbi.nlm.nih.gov/pubmed/22733396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-012-1308-3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares